Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

Deutsche Bank lowered the firm’s price target on TransUnion (TRU) to $115 from $118 and keeps a Buy rating on the shares following the “solid” ...

Deutsche Bank’s shift to Google Cloud powers up its AI capabilities, optimising operations and slashing process times ...

Deutsche Bank AG was fined €10 million ($10.3 million) by Spain’s securities regulator CNMV for selling derivatives to ...

Deutsche Bank has a wake up call for analysts who denied Trump would deliver on tax rhetoric—but UBS is questioning how ...

Deutsche Bank Aktiengesellschaft's Q4 results showed an 8.6% revenue increase but a 17% drop in pre-tax profit. Click here to ...

Spanish supervisors said on Monday they had fined Germany's Deutsche Bank 10 million euros ($10.32 million) for infringements ...

UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Tuesday, Ratings reports. The brokerage ...

Deutsche Bank, one of the most influential banks in Europe, said it is considering exiting some businesses after both fourth quarter and full 2024 year profits fell more than anticipated.

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage ...